Veröffentlichungen 2011

1. Apostolopoulos DJ, Dimitrakopoulou-Strauss A, Hohenberger P, Roumia S, Strauss LG. Parametric images via dynamic (18)F-fluorodeoxyglucose positron emission tomographic data acquisition in predicting midterm outcome of liver metastases secondary to gastrointestinal stromal tumours. Eur J Nucl Med Mol Imaging 2011;38(7):1212-23.

2. Askoxylakis V, Zitzmann-Kolbe S, Zoller F, Altmann A, Markert A, Rana S, Marr A, Mier W, Debus J, Haberkorn U. Challenges in Optimizing a Prostate Carcinoma Binding Peptide, Identified through the Phage Display Technology. Molecules 2011;16:1559-1578.

3. Askoxylakis V, Millonig G, Wirkner U, Schwager C, Rana S, Altmann A, Haberkorn U, Debus J, Mueller S, Huber PE. Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiency. Radiat Oncol 2011;6(1):35.

4. Cheng C, Komljenovic D, Pan L, Dimitrakopoulou-Strauss A, Strauss L, Bäuerle T. Evaluation of treatment response of cilengitide in an experimental model of breast cancer bone metastasis using dynamic PET with 18F-FDG. Hell J Nucl Med 2011;14(1):15-20.

5. Dimitrakopoulou-Strauss A, Seiz M, Tuettenberg J, Schmieder K, Eisenhut M, Haberkorn U, Strauss LG. Pharmacokinetic Studies of 68Ga-Labeled Bombesin (68Ga-BZH3) and F-18 FDG PET in Patients With Recurrent Gliomas and Comparison to Grading: Preliminary Results. Clin Nucl Med 2011;36(2):101-8.

6. Dinkel J, Thieke C, Plathow C, Zamecnik P, Prüm H, Huber PE, Kauczor HU, Schlemmer HP, Zechmann CM. Respiratory-Induced Prostate Motion : Characterization and Quantification in Dynamic MRI. Strahlenther Onkol 2011;187(7):426-432.

7. Duerr J, Gruner M, Schubert SC, Haberkorn U, Bujard H, Mall MA. Use of a New Generation Reverse Tetracycline Transactivator System for Quantitative Control of Conditional Gene Expression in the Murine Lung. Am J Respir Cell Mol Biol 2011;44(2)244-254.

8. Giesel FL, Mehndiratta A, Hempel A, Hempel E, Wuestenberg T, Kress KR, Essig M, Schröder J. Improvement of auditory hallucinations and reduction of primary auditory area's activation following TMS. Eur J Radiol 2011; [Epub ahead of print].

9. Giesel FL, Mehndiratta A, Hohmann N, Seidl U, Essig M, Schröder J. Stability of cerebral activation patterns in patients with first-episode schizophrenia and a healthy control group using functional MRI. Eur J Radiol 2011; [Epub ahead of print].

10. Giesel FL, Kratochwil C, Wulfert S, Kauczor HU, Haberkorn H, Ley S. Comparison of Lesion Detection and Characterization in Patients with Neuroendocrine Tumors Using DOTATOC-PET in Correlation with Contrast-enhanced MRI and Contrast-enhanced CT. Eur J Radiol 2011; in print.

11. Haberkorn U, Markert A, Mier W, Askoxylakis V, Altmann A. Molecular imaging of tumor metabolism and apoptosis. Oncogene 2011;30(40):4141-51.

12. Hauser T, Thomann P, Giesel FL, Schröder J, Essig M. Normal aging of the Brain. Journal of Magnetic Resonance Imaging JMRI; in print.

13. Hausmann D, Jochum S, Utikal J, Hoffmann RC, Zechmann C, Neff KW, Goerdt S, Schoenberg SO, Dinter DJ. Comparison of the diagnostic accuracy of whole-body MRI and whole-body CT in stage III/IV malignant melanoma. J Dtsch Dermatol Ges 2011;9(3):212-22.

14. Hillengass J, Stieltjes B, Bäuerle T, McClanahan F, Heiss C, Hielscher T, Wagner-Gund B, Habetler V, Goldschmidt H, Schlemmer HP, Delorme S, Zechmann CM. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals. Acta Radiol 2011;52(3):324-30.

15. Hillengass J, Bäuerle T, Bartl R, Andrulis M, McClanahan F, Laun FB, Zechmann CM, Shah R, Wagner-Gund B, Simon D, Heiss C, Neben K, Ho AD, Schlemmer HP, Goldschmidt H, Delorme S, Stieltjes B. Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology. Br J Haematol 2011;153(6):721-728.

16. Jensen AD, Münter MW, Bischoff HG, Haselmann R, Haberkorn U, Huber PE, Thomas M, Debus J, Herfarth KK. Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: The NEAR trial. Cancer 2011;117:2986-2994.

17. Kratochwil C, López-Benítez R, Mier W, Haufe S, Isermann B, Kauczor HU, Choyke PM, Haberkorn U, Giesel FL. Hepatic arterial infusion enhances DOTATOC radiopeptide therapy in patients with neuroendocrine liver metastases. Endocr Relat Cancer 2011;18(5):595-602.

18. Kristen AV, Haufe S, Schonland SO, Hegenbart U, Schnabel PA, Röcken C, Hardt S, Lohse P, Ho AD, Haberkorn U, Dengler TJ, Altland K, Katus HA. Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis. Int J Cardiol 2011; [Epub ahead of print].

19. Lagemaat MW, Zechmann CM, Fütterer JJ, Weiland E, Lu J, Villeirs GM, Holshouser BA, van Hecke P, Lemort M, Schlemmer HP, Barentsz JO, Roell SO, Heerschap A, Scheenen TW. Reproducibility of 3D (1) H MR spectroscopic imaging of the prostate at 1.5T.J Magn Reson Imagingdoi: 10.1002/jmri.22827. [Epub ahead of print].

20. Lindner T, Kolmar H, Haberkorn U, Mier M. DNA Libraries for the Construction of Phage Libraries: Statistical and Structural Requirements and Synthetic Methods. Molecules 2011;16:1625-1641.

21. Lorenzen S, von Gall C, Stange A, Haag GM, Weitz J, Haberkorn U, Lordick F, Weichert W, Abel U, Debus J, Jager D, Munter MW. Sequential FDG-PET and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Oesophago-gastric Junction (AEG): The Heidelberg Imaging Program in Cancer of the Oesophago-gastric junction during Neoadjuvant Treatment: HICON Trial. BMC Cancer 2011;11(1):266.

22. Marr A, Markert A, Altmann A, Askoxylakis V, Haberkorn U. Biotechnology techniques for the development of new tumor specific peptides. Methods 2011;55:215-222.

23. Martincich L, Faivre-Pierret M, Zechmann CM, Corcione S, van den Bosch HC, Peng WJ, Petrillo A, Siegmann KC, Heverhagen JT, Panizza P, Gehl HB, Diekmann F, Pediconi F, Ma L, Gilbert FJ, Sardanelli F, Belli P, Salvatore M, Kreitner KF, Weiss CM, Zuiani C.Multicenter, Double-Blind, Randomized, Intraindividual Crossover Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine for Breast MR Imaging (DETECT Trial). Radiology 2011;258(2):396-408.

24. Oltmanns D, Zitzmann-Kolbe S, Mueller A, Bauder-Wuest U, Schaefer M, Eder M, Haberkorn U, Eisenhut M. Zn(II)-bis(cyclen) complexes and the imaging of apoptosis/necrosis. Bioconjug Chem 2011;22(12):2611-2624.

25. Poon DP, Langkals JW, Giesel FL, Knopp MV, Tengg-Kobligk H. Internet-based videoconferencing and data collaboration for the imaging community. J Comput Assist Tomogr 2011;35(6):753-61.

26. Purz S, Mauz-Körholz C, Körholz D, Hasenclever D, Krausse A, Sorge I, Ruschke K, Stiefel M, Amthauer H, Schober O, Kranert WT, Weber WA, Haberkorn U, Hundsdörfer P, Ehlert K, Becker M, Rössler J, Kulozik AE, Sabri O, Kluge R. 18F]fluorodeoxyglucose Positron Emission Tomography for Detection of Bone Marrow Involvement in Children and Adolescents With Hodgkin's Lymphoma. J Clin Oncol 2011;29:3523-3528.

27. Scheenen TWJ, Fütterer J, Weiland E, van Hecke P, Lemort M, Zechmann CM, Schlemmer HP, Broome D, Villeirs G, Lu J, Barentsz J, Roell S, Heerschap A. Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation study. Invest Radiol 2011;46(1):25-33.

28. Schmitt T, Lehner B, Kasper B, Bischof M, Roeder F, Dietrich S, Dimitrakopoulou-Strauss A, Strauss LG, Mechtersheimer G, Wuchter P, Ho AD, Egerer G. A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma. BMC Cancer 2011;11(1):510.

29. Schönknecht OD, Hunt A, Toro P, Guenther T, Henze M, Haberkorn U, Schröder J. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease. Clin EEG Neurosci 2011;42(2):71-76.

30. Schuster L, Schenk E, Giesel FL, Hauser T, Gerigk L, Zabel-Du-Bois A, Essig M. Changes in AVM angio-architecture and hemodynamics after stereotactic radiosurgery assessed by dynamic MRA and phase contrast flow assessments: a prospective follow-up study. Eur Radiol 2011;21(6):1267-76.

31. Strauss LG, Pan L, Cheng C, Haberkorn U, Dimitrakopoulou-Strauss A. Shortened acquisition protocols for the quantitative assessment of the 2-tissue compartment model using dynamic PET/CT 18F-FDG studies. J Nucl Med 2011;52:379-385.

32. Strauss LG, Koczan D, Klippel S, Pan L, Cheng C, Haberkorn U, Willis S, Dimitrakopoulou-Strauss A. Impact of Cell-Proliferation-Associated Gene Expression on 2-Deoxy-2-[(18)F]fluoro-D:-Glucose (FDG) Kinetics as Measured by Dynamic Positron Emission Tomography (dPET) in Colorectal Tumors. Mol Imaging Biol 2011;13(6):1290-300.

33. Strauss LG, Koczan D, Seiz M, Tuettenberg T, Schmieder K, Pan L, Cheng C, Dimitrakopoulou-Strauss A. Correlation of the Ga-68-Bombesin analog Ga-68-BZH3 with Receptors Expression in Gliomas as Measured by Quantitative Dynamic Positron Emission Tomography (dPET) and Gene Arrays. Mol Imaging Biol 2011; [Epub ahead of print].

34. Takesh M, Zechmann CM, Haufe S, Giesel FL, Kratochwil C. Impact of geometric mean imaging in the accurate determination of partial function in MAG3 renal scanning in a patient with retroperitoneal mass. Radiology Case 2011;5(6):9-17.

35. Takesh M, Zechmann CM, Kratochwil C, Sahli H, Zein M. Positive somatostatin receptor scintigraphy in accessory spleen mimicking recurrent neuroendocrine tumor. Radiology Case Reports 2011;6:1-3.

36. Unterhinninghofen R, Giesel FL, Dillmann R. MEDIFRAME - Remote volume rendering visualization framework. Conf Proc IEEE Eng Med Biol Soc 2011;201:2368-71.

37. Wipfler B, Donner S, Zechmann CM, Springer J, Siebold R, Paessler HH. Anterior cruciate ligament reconstruction using patellar tendon versus hamstring tendon: a prospective comparative study with 9-year follow-up. Arthroscopy 2011;27(5):653-665.

38. Zechmann CM, Traine L, Meißner T, Wagner-Gund B, Giesel FL, Goldschmidt H, Delorme S, Hillengass J. Parametric histogram analysis of dynamic contrast-enhanced MRI in multiple myeloma: A technique to evaluate angiogenic response to therapy ? Acad Radiol 2011; [Epub ahead of print].

39. Zoller F, Haberkorn U, Mier W. Miniproteins as phage display-scaffolds for cinical applications. Molecules 2011;16(3):2467-85.

40. Zoller F, Schwaebel, T, Markert A, Haberkorn U, Mier W. Engineering and functionalization of the disulfide-constrained miniprotein Min-23 as a scaffold for diagnostic application. ChemMedChem 2011; accepted.

1. Giesel FL, Anandaraj P, Zechmann C, Mehndiratta A. Nuclear Medicine. In: Miller CG, Krasnow J, Schwartz LH (eds.). An overview of Imaging Techniques, Clinical Applications and Trials in Clinical Trials. Springer Verlag 2011; in print.

2. Giesel FL, Tengg-Kobligk H. Contrast Media in MRI in Imaging in Clinical Trials in Medical Imaging in Clinical Trials. In: Miller CG, Krasnow J, Schwartz LH (eds.). Springer Verlag 2011; in print.

3. Giesel FL, Kratochwil C. New approaches on radio-peptide therapy delivery in patients with somatostatin receptor positive tumors in Drug Delivery Applications of Noninvasive Imaging: Validation from Biodistribution to Sites of Action. In: Jackson EF, Tian M, Li C. (eds.). Wiley-Blackwell John Wiley & Sons, Inc 2011; in print.

4. Mehndiratta A, Giesel FL. Brain Tumor Imaging. In: Diagnostic Techniques and Surgical Management of Brain Tumors. Abujamra AL (ed.). InTech 2011. pp 27-42. ISBN 9789533075891.

5. Strauss LG, Dimitrakopoulou-Strauss A. Functional Imaging. In: Bernier J (ed.). Head and Neck Cancer: Multimodality Management. Springer Science New York + Business Media, LCC 2011; pp 235-240. ISBN 9781441994639.

6. Zechmann C. Kapitel Radiologie. In: Mediscript . Hammerexamen 10/2006 –10/2010 Alle Original-IMPP-Prüfungsfragen des 2. Abschnitts der Ärztlichen Prüfung, CD-Rom. Urban & Fischer bei Elsevier; 2011; ISBN 978343743892-9.